Literature DB >> 15669556

Treatment of atrophic vaginitis with topical conjugated equine estrogens in postmenopausal Asian women.

N Raymundo1, B Yu-cheng, H Zi-yan, C Huey Lai, K Leung, R Subramaniam, C Bin-rong, Y S Ling, N Nasri, N Calimon.   

Abstract

OBJECTIVE: We investigated the effects of 2 months of treatment with topical estrogens on atrophic vaginitis and gynecological health in Asian women. STUDY
DESIGN: Multicenter, open-label trial of 150 postmenopausal women age <70 years with atrophic vaginitis. Women applied conjugated equine estrogens (CEE) vaginal cream (0.625 mg/g) once daily on days 1-21 of two 28-day cycles. Changes in the vaginal maturation index (VMI) from baseline to days 21 (month 1) and 49 (month 2) were the primary outcome. Physiological changes were assessed by the Genital Health Clinical Examination (GHCE).
RESULTS: The VMI was significantly improved (p < 0.001) from baseline at each assessment period. The significant improvement in GHCE from baseline after 1 month (p < 0.001) was maintained at 2 months.
CONCLUSIONS: Vaginal treatment with CEE cream for 21 days of two consecutive 28-day cycles resulted in beneficial changes in the vaginal tissues and induced an overall genital health pattern more characteristic of the premenopausal state.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15669556     DOI: 10.1080/13697130400003147

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  8 in total

1.  Comparison of the Effects of Vaginal Royal Jelly and Vaginal Estrogen on Quality of Life, Sexual and Urinary Function in Postmenopausal Women.

Authors:  Fatemeh Seyyedi; Mahmoud Rafiean-Kopaei; Sepideh Miraj
Journal:  J Clin Diagn Res       Date:  2016-05-01

Review 2.  Assessment of vaginal atrophy: a review.

Authors:  M A Weber; J Limpens; J P W R Roovers
Journal:  Int Urogynecol J       Date:  2014-07-22       Impact factor: 2.894

Review 3.  Tissue-selective estrogen complexes: a promising option for the comprehensive management of menopausal symptoms.

Authors:  David F Archer
Journal:  Drugs Aging       Date:  2010-07-01       Impact factor: 3.923

4.  A survey of the therapeutic effects of Vitamin E suppositories on vaginal atrophy in postmenopausal women.

Authors:  Aazam Parnan Emamverdikhan; Nahid Golmakani; Sayyed ASajadi Tabassi; Malihe Hassanzadeh; Nooriyeh Sharifi; Mohammad Taghi Shakeri
Journal:  Iran J Nurs Midwifery Res       Date:  2016 Sep-Oct

5.  Visual improvements in vaginal mucosa correlate with symptoms of VVA: data from a double-blind, placebo-controlled trial.

Authors:  James A Simon; David F Archer; Risa Kagan; Brian Bernick; Shelli Graham; Ginger D Constantine; Sebastian Mirkin
Journal:  Menopause       Date:  2017-09       Impact factor: 2.953

6.  Comparison between vaginal royal jelly and vaginal estrogen effects on quality of life and vaginal atrophy in postmenopausal women: a clinical trial study.

Authors:  Fatemeh Seyyedi; Mahmoud Rafiean Kopaei; Sepideh Miraj
Journal:  Electron Physician       Date:  2016-11-25

Review 7.  Local oestrogen for vaginal atrophy in postmenopausal women.

Authors:  Anne Lethaby; Reuben Olugbenga Ayeleke; Helen Roberts
Journal:  Cochrane Database Syst Rev       Date:  2016-08-31

8.  Comparison of the Vaginal Microbiomes of Premenopausal and Postmenopausal Women.

Authors:  Karol Gliniewicz; G Maria Schneider; Benjamin J Ridenhour; Christopher J Williams; Yuli Song; Miranda A Farage; Kenneth Miller; Larry J Forney
Journal:  Front Microbiol       Date:  2019-02-14       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.